For the period under review , Group revenue has been increased by 48.28% (or RM29.49 million) from RM 61.08 million to RM 90.57 million whereby Supercomal Medical Product(SMP) contribute 20.61 million of the sales increment. The profit after tax increased by 40.44 % ( or RM 4.11 million) from RM 10.15 million to RM 14.26 million after the amortisation of RM 3 million intangible assets. The improvement in profit mainly due to contribution from SMP which accounted 80% of profit for the period .
Medical business is contributing 2/3 of the revenue growth.
Being the person who is directly involved in Sapien 3 valve by Edwards Lifesciences , it's the only valve in the world that has direct competition with the valve by medtronic. The Asian penetration of this valve is still at the beginning stage, but soon we will see an increase in the usage of sapien 3. The only downside is the vale costs about 100k. However, it's been widely used in European countries. What I can see is the revenue for it will continue to grow in near future because of the new research paper on the usage of the valve named Partner III trial. Hence, it's quite a safe assumption that the revenue will keep growing from the medical side.
Technical Buy - SCOMNET-WA (0001WA) - PublicInvest Research | I3investor Sign In
PublicInvest Research click to expand contents Technical Buy - SCOMNET-WA (0001WA) Author: PublicInvest Publish date: Wed, 29 Jan 2020, 6:11 PM Close
Target Price: RM0.535, RM0.590 Last closing price: RM0.490 Potential return: 9.1%, 20.4% Support: RM0.440 Stop Loss: RM0.425 Possible for further upside. SCOMNET-WA rebounded off its key support level. Improving RSI and MACD indicators currently signal reasonable entry level, with anticipation of continuous improvement in both momentum and trend in near term. Should resistance level of RM0.515 be broken, it may continue to lift price higher to subsequent resistance levels of RM0.535 and RM0.590. Note that the maturity date of SCOMNET-WA is on 19 June 2024.
However, failure to hold on to support level of RM0.440 may indicate weakness in the share price and hence, a cut-loss signal
80% of raw material cost of cable wire is copper. Copper price has been tumbling down for the past months from USD6300 to 5500/ton and it is still coming down. For sure this lower raw material cost will boost their margin.
Signficant Revenue Growth Factors: 1. Major Clients: Edward Lifesciences + Ambu both had huge sales growth Edward Lifesciences: • Q4 TAVR1 sales grew 29%; underlying sales grew 30% • SAPIEN 3 transcatheter heart valve received expansion in Europe 2. Edward Lifesciences received FDA approval for 2 transcatheter heart valve systems 2. Medical sector growth 3. Malaysia Budget 2020: RM227M for upgrading medical equipment 4. Edwards Lifesciences Ltd set up its second regional business hub in KL 5. Copper price stayed low in Q4 2019
Healthcare and infrastructure to benefit TheStar Sat, Mar 28, 2020 09:10am - 1 day ago While all eyes have been on the glove manufacturers, little attention has been given to the makers of health equipment and products, which in all honesty, have seen a similar rise in their demand.
“For example, companies like Nova Wellness Group Bhd and APEX HEALTHCARE BHD which sells supplements like Vitamin C, sanitizers and face masks, the demand for these products have also been through the roof, ” says one analyst.
Meanwhile equipment providers such as UWC Holdings Bhd and Supercomnet Technologies Bhd supplies devices and components for Covid-19 testing.
Earlier this week, hospital furniture manufacturer and provider LKL International Bhd saw its share price double in one week, as investors anticipated further contract wins for the company.
On March 25, LKL was awarded a contract for the supply of personal protective equipment to public hospitals in Sarawak for RM6.57mil.
Besides LKL, the other supplier of hospital equiment is BCM Alliance Bhd.
Listed hospital operators include IHH HEALTHCARE BHD and KPJ Healthcare Bhd.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
tracker113
273 posts
Posted by tracker113 > 2019-11-27 17:58 | Report Abuse
Result out. Rev record highest... but profit decrease